Healthcare & Regulatory in Sweden Key Players - Novartis, Pfizer, Merck, Orifarm, and Orexo Market Analysis & Forecast 2018 to 2022

Healthcare & Regulatory in Sweden

Overview

Sweden is one of the largest healthcare market, with a strong focus on pharma R&D. It spends approximately 11% of it’s GDP on healthcare. The pharmaceutical market increased from SEK36.2 billion ($4.76 billion) in 2009 to SEK42.6 billion ($4.98 billion) in 2016, at a CAGR of 2.4% in terms of Swedish Krona and 0.7% in terms of US dollars .

It is expected to reach SEK 47.9 billion ($5.15 billion) in 2021. The Swedish medical device market was valued at $1.96 billion in 2009, which increased to $2.60 billion in 2016.The main segments in 2016 were in vitro diagnostics, ophthalmic devices, cardiovascular devices, healthcare IT and orthopedic devices. Introduction of new medicines for the treatment of Hepatitis C and reduced savings associated with patent expirations are the contributors to pharmaceutical market growth.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3079943-countryfocus-healthcare-regulatory-and-reimbursement-landscape-sweden

 

Healthcare & Regulatory in Sweden Industry Major Outlook

The report provides information on the healthcare, regulatory, and reimbursement landscape in Sweden, and includes - 
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers 
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, Merck, Orifarm, AstraZeneca and Orexo) and profiles and SWOT analyses of the major players in the medical device market (Roche Diagnostics, Essilor, Medtronic, DePuy Synthes and GE Healthcare) 
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Sweden 
- Porter’s five forces analysis for pharmaceutical and medical devices market of Sweden 
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices 
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure 
- An overview of the opportunities for and challenges to growth in the Swedish healthcare market..

Healthcare & Regulatory in Sweden - Competitive Analysis

Key players are making innovative developments in Healthcare & Regulatory in Sweden industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Sweden. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Sweden.

 Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3079943-countryfocus-healthcare-regulatory-and-reimbursement-landscape-sweden

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.